Lightstone Ventures
2884 Sandhill Road, STE 121Menlo Park, CA 94025
Firm Size
- Assets Under Management (AUM):$732 Million
- Number of Funds:6
- Employees:
- Firm Type:Venture Capital
- Focus Areas:
Software & Technology
Services
Healthcare
Description
Lightstone Ventures is a venture capital firm based in Menlo Park, California. The firm primarily focuses on early-stage investments in the healthcare technology and life sciences sectors. Founded in 2012, Lightstone Ventures aims to provide critical support and capital to emerging companies that have the potential to make a significant impact in the healthcare industry. The firm takes a hands-on approach in working closely with its portfolio companies, providing strategic guidance, operational support, and industry expertise to help accelerate their growth. Lightstone Ventures typically leads or co-leads funding rounds and has a strong network of partners and co-investors. Lightstone Ventures has a broad investment scope within healthcare, including areas such as medical devices, biopharmaceuticals, diagnostics, digital health, and healthcare services. The firm seeks out companies that leverage innovative technologies and have the potential to disrupt traditional healthcare models. The team at Lightstone Ventures brings together a diverse set of experience and backgrounds, with deep knowledge of the healthcare industry. They actively collaborate with entrepreneurs and industry experts to identify and invest in pioneering companies that are poised to address critical healthcare challenges. Overall, Lightstone Ventures plays a crucial role in supporting early-stage healthcare companies in their growth journey, offering financial resources, industry expertise, and strategic guidance to help them achieve their potential and make a positive impact on patient outcomes and the healthcare landscape.Latest News
Powered by
Aug 02, 2023: Horizon Technology Finance Provides $15 Million Venture Loan Facility to Tallac Therapeutics
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $15 million venture loan facility to Tallac Therapeutics, Inc. ("Tallac"), of which $5 million has been initially funded.
Jun 22, 2023: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics